BA6b9

N/A

Report date: 2025/03/13 16:24:33

Base Information

Drug NameBA6b9

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionIntermediate conductance calcium-activated potassium channel protein 4 blockers

TargetsIntermediate conductance calcium-activated potassium channel protein 4

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTel Aviv University

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

ATC CodeN/A